Rigel Pharmaceuticals

RIGL

RIGL
Rigel Pharmaceuticals Stock Quote
$1.64 $0.04 2.2%
BATS BZX Real Time Price as of October 18, 2019, 4:00 p.m. EDT View Interactive RIGL Charts

The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases.

News & Analysis: Rigel Pharmaceuticals

The Fool has written over 100 articles on Rigel Pharmaceuticals.

All

Market Moves

Earnings


Is Rigel Pharmaceuticals a Buy?

The stock rose after a promising full-year 2018 earnings report and then rapidly began sliding back to multiyear lows. What's going on?





Is Rigel Pharmaceuticals a Buy?

This small-cap stock had a rough 2018, but the company just launched its first drug product. Will it be enough to regain Wall Street's trust?






Interactive Chart